|
1
|
Siegel RL, Giaquinto AN and Jemal A:
Cancer statics, 2024. CA Cancer J Clin. 74:12–49. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Korea National Cancer CenterNational
Cancer Registration Project Annual Report (2020 Cancer Registration
Statistics), . https://ncc.re.kr/cancerStatsView.ncc?bbsnum=638&searchKey=total&searchValue=&pageNum=1May
19–2023(In Korean).
|
|
3
|
Faraji F, Rettig EM, Tsai HL, El Asmar M,
Fung N, Eisele DW and Fakhry C: The prevalence of human
papillomavirus in oropharyngeal cancer is increasing regardless of
sex or race, and the influence of sex and race on survival is
modified by human papillomavirus tumor status. Cancer. 125:761–769.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kang EJ, Lee YG, Keam B, Choi JH, Kim JS,
Park KU, Lee KE, Kim HJ, Lee KW, Kim MK, et al: Characteristics and
treatment patterns in older patients with locally advanced head and
neck cancer (KCSG HN13-01). Korean J Intern Med. 37:190–200. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lechner M, Liu J, Masterson L and Fenton
TR: HPV-associated oropharyngeal cancer: Epidemiology, molecular
biology and clinical management. Nat Rev Clin Oncol. 19:306–327.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rettig EM, Fakhry C, Khararjian A and
Westra WH: Age profile of patients with oropharyngeal squamous cell
carcinoma. JAMA Otolaryngol Head Neck Surg. 144:538–539. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ang KK, Harris J, Wheeler R, Weber R,
Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, Lu C,
et al: Human papillomavirus and survival of patients with
oropharyngeal cancer. N Engl J Med. 363:24–35. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cao X, Hou J, An Q, Assaraf YG and Wang X:
Towards the overcoming of anticancer drug resistance mediated by
p53 mutations. Drug Resist Updat. 49:1006712020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Amin MB, Edge SB, Greene FL, Byrd DR,
Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR,
Sullivan DC, et al: AJCC Cancer Staging Manual. 8th edition.
Springer; New York, NY: 2017
|
|
10
|
Pfister DG, Spencer S, Adelstein D, Adkins
D, Anzai Y, Brizel DM, Bruce JY, Busse PM, Caudell JJ, Cmelak AJ,
et al: Head and Neck Cancers, Version 2.2024, NCCN Clinical
Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024.
|
|
11
|
Marur S, Li S, Cmelak AJ, Gillison ML,
Zhao WJ, Ferris RL, Westra WH, Gilbert J, Bauman JE, Wagner LI, et
al: E1308: Phase II trial of induction chemotherapy followed by
reduced-dose radiation and weekly cetuximab in patients with
HPV-associated resectable squamous cell carcinoma of the
oropharynx-ECOG-ACRIN Cancer Research Group. J Clin Oncol.
35:490–497. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Seiwert TY, Foster CC, Blair EA, Karrison
TG, Agrawal N, Melotek JM, Portugal L, Brisson RJ, Dekker A,
Kochanny S, et al: OPTIMA: A phase II dose and volume de-escalation
trial for human papillomavirus-positive oropharyngeal cancer. Ann
Oncol. 30:16732019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kang JJ, Yu Y, Chen L, Zakeri K, Gelblum
DY, McBride SM, Riaz N, Tsai CJ, Kriplani A, Hung TKW, et al:
Consensuses, controversies, and future directions in treatment
deintensification for human papillomavirus-associated oropharyngeal
cancer. CA Cancer J Clin. 73:164–197. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim MJ, Ki MS, Kim K, Shim HJ, Hwang JE,
Bae WK, Chung IJ, Lee DH, Lee JK, Yoon TM, et al: Different protein
expression associated with chemotherapy response in oropharyngeal
cancer according to HPV status. BMC Cancer. 14:8242014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
World Health Organization and Regional
Office for the Western Pacific, . The Asia-Pacific perspective:
redefining obesity and its treatment. Health Communications
Australia; Sydney: pp. 182000, https://iris.who.int/handle/10665/206936May
19–2023
|
|
16
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chow LQM: Head and Neck Cancer. N Engl J
Med. 382:60–72. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen SY, Massa S, Mazul AL, Kallogjeri D,
Yaeger L, Jackson RS, Zevallos J and Pipkorn P: The association of
smoking and outcomes in HPV-positive oropharyngeal cancer: A
systemic review. Am J Otolaryngol. 41:1025922020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lai YH, Su CC, Wu SY, Hsueh WT, Wu YH,
Chen HHW, Hsiao JR, Liu CH and Tsai YS: Impact of alcohol and
smoking on outcomes of HPV-related oropharyngeal cancer. J Clin
Med. 11:65102022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ferrari D, Ghi MG, Franzese C, Codeca C,
Gau M and Fayette J: The slippery role of induction chemotherapy in
head and neck cancer: Myth and reality. Front Oncol. 10:72020.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cohen EE, Karrison TG, Kocherginsky M,
Mueller J, Egan R, Huang CH, Brockstein BE, Agulnik MB, Mittal BB,
Yunus F, et al: Phase III randomized trial of induction
chemotherapy in patients with N2 or N3 locally advanced head and
neck cancer. J Clin Oncol. 32:2735–2743. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ghi MG, Paccagnella A, Ferrari D, Foa P,
Alterio D, Codecà C, Nolè F, Verri E, Orecchia R, Morelli F, et al:
Induction TPF followed by concomitant treatment versus concomitant
treatment alone in locally advanced head and neck cancer. A phase
II–III trial. Ann Oncol. 28:2206–2212. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Haddad R, O'Neill A, Rabinowits G, Tishler
R, Khuri F, Adkins D, Clark J, Sarlis N, Lorch J, Beitler JJ, et
al: Induction chemotherapy followed by concurrent chemoradiotherapy
(sequential chemoradiotherapy) versus concurrent chemoradiotherapy
alone in locally advanced head and neck cancer (PARADIGM): A
randomised phase 3 trial. Lancet Oncol. 14:257–264. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Abdelmeguid AS, Teeramatwanich W, Roberts
DB, Amit M, Ferraroto R, Glisson BS, Kupferman ME, Su SY, Phan J,
Garden AS, et al: Neoadjuvant chemotherapy for locoregionally
advanced squamous cell carcinoma of the paranasal sinuses. Cancer.
127:1788–1795. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bossi P, Lo Vullo S, Guzzo M, Mariani L,
Granata R, Orlandi E, Locati L, Scaramellini G, Fallai C and
Licitra L: Preoperative chemotherapy in advanced resectable OCSCC:
long-term results of a randomized phase III trial. Ann Oncol.
25:462–466. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee YG, Kang EJ, Keam B, Choi JH, Kim JS,
Park KU, Lee KE, Kim HJ, Lee KW, Kim MK, et al: Induction
chemotherapy as a prognostication index and guidance for treatment
of locally advanced head and neck squamous cell carcinoma: The
concept of chemo-selection (KCSG HN13-01). Cancer Res Treat.
54:109–117. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang Q, Xu T, Shen C, Qian W, Ying H, He
X, Wang Y, Ji Q, Hu C, Zhou X and Lu X: Response to induction
chemotherapy predicts survival outcomes in oropharyngeal cancer.
Cancer Med. 12:9175–9185. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yoo SH, Ock CY, Keam B, Park SJ, Kim TM,
Kim JH, Jeon YK, Chung EJ, Kwon SK, Hah JH, et al: Poor prognostic
factors in human papillomavirus-positive head and neck cancer: Who
might not be candidates for de-escalation treatment? Korean J
Intern Med. 34:1313–1323. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Broughman JR, Xiong DD, Moeller BJ,
Contrera KJ, Prendes BL, Lamarre ED, Ku JA, Burkey BB, Woody NM,
Joshi NP, et al: Rethinking the 10-pack-year rule for favorable
human papillomavirus-associated oropharynx carcinoma: A
multi-institution analysis. Cancer. 126:2784–2790. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fakhry C, Zhang Q, Nguyen-Tan PF,
Rosenthal DI, Weber RS, Lambert L, Trotti AM III, Barrett WL,
Thorstad WL, Jones CU, et al: Development and validation of
nomograms predictive of overall and progression-free survival in
patients with oropharyngeal cancer. J Clin Oncol. 35:4057–4065.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang SH, Xu W, Waldron J, Siu L, Shen X,
Tong L, Ringash J, Bayley A, Kim J, Hope A, et al: Refining
American Joint Committee on Cancer/Union for International Cancer
Control TNM stage and prognostic groups for human
papillomavirus-related oropharyngeal carcinomas. J Clin Oncol.
33:836–845. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chatsirisupachai K, Lagger C and de
Magalhaes JP: Age-associated differences in the cancer molecular
landscape. Trends Cancer. 8:962–971. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
de la Iglesia JV, Slebos RJC, Martin-Gomez
L, Wang X, Teer JK, Tan AC, Gerke TA, Aden-Buie G, van Veen T,
Masannat J, et al: Effects of tobacco smoking on the tumor immune
microenvironment in head and neck squamous cell carcinoma. Clin
Cancer Res. 26:1474–1485. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Khwaja SS, Baker C, Haynes W, Spencer CR,
Gay H, Thorstad W, Adkins DR, Nussenbaum B, Chernock RD, Lewis JS
Jr and Wang X: High E6 gene expression predicts for distant
metastasis and poor survival in patients with HPV-positive
oropharyngeal squamous cell carcinoma. Int J Radiat Oncol Biol
Phys. 95:1132–1141. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Flon CH, Haeggblom L, Holzhauser S,
Kostopoulou ON, Zupancic M, Dalianis T, Munck-Wikland E, Marklund L
and Näsman A: High levels of FGF11 correlate with poor survival in
patients with human papillomavirus (HPV)-positive oropharyngeal
squamous cell carcinoma. Cancers (Basel). 15:19542023. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
de Bakker T, Journe F, Descamps G, Saussez
S, Dragan T, Ghanem G, Krayem M and Van Gestel D: Restoring p53
function in head and neck squamous cell carcinoma to improve
treatments. Front Oncol. 11:7999932021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dogan S, Xu B, Middha S, Vanderbilt CM,
Bowman AS, Migliacci J, Morris LGT, Seshan VE and Ganly I:
Identification of prognostic molecular biomarkers in 157
HPV-positive and HPV-negative squamous cell carcinomas of the
oropharynx. Int J Cancer. 145:3152–3162. 2019. View Article : Google Scholar : PubMed/NCBI
|
